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Abstract 27 
Objectives: To assess the process of establishment of the intestinal microbiota in 28 
very-low birth-weight preterm infants and to evaluate the impact of perinatal factors, 29 
such as delivery mode and perinatal antibiotics, in this process.  30 
Study design: We used 16S rRNA gene sequence-based microbiota analysis and 31 
quantitative PCR to evaluate the establishment of the microbiota.  We also evaluated 32 
factors affecting the microbiota establishment, during the first three months of life in 33 
preterm infants (n=27) compared with full-term babies (n=13).  34 
Results: Immaturity affects the microbiota as indicated by a reduced percentage of 35 
the family Bacteroidaceae during the first months of life or by a higher initial 36 
percentage of Lactobacillaceae in preterm infants compared with full term infants. 37 
Perinatal antibiotics use, including intrapartum antimicrobial prophylaxis, affects the 38 
establishment of gut microbiota, as indicated by increased Enterobacteriaceae family 39 
organisms in the infants.  40 
Conclusion: Prematurity and perinatal antibiotic administration strongly affect the 41 
initial establishment of microbiota with potential consequences for later health. 42 
 43 
Introduction 44 
The microbial colonization of the intestine of newborns starts with facultative 45 
anaerobes and continues with strict anaerobic genera, with several factors, such as 46 
feeding habits or gestational age, affecting this process1. This initial microbial 47 
colonization results essential for the normal development of the host2, with the early 48 
neonatal period representing the most important moment for the microbiota-induced 49 
host-homeostasis3. However, with the exception of delivery mode and feeding habits, 50 
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the effect of other factors on the process of microbiota development in the newborn 51 
remains poorly understood. 52 
Despite the high inter-individual variability, metagenomic and 16S rRNA gene 53 
sequencing studies have recently identified the existence of different microbiota 54 
enterotypes in humans4, and microbiota alterations related with diseases have been 55 
observed5,6. In spite of the importance of the initial steps of microbiota establishment 56 
for the later well-being, only recently some data on preterm infants became 57 
available7-14. In many of these works infants suffering necrotizing enterocolitis (NEC) 58 
and/or sepsis are compared with those remaining healthy and very often the studies 59 
include small cohorts and do not extend beyond the first month of life. In spite of 60 
these limitations, the available data indicate that the microbiota of preterm differs 61 
from that of full-term infants, suggesting potential targets for microbiota modulation.  62 
The fecal microbiota profile of the healthy full-term, vaginally-delivered, 63 
exclusively breast-fed (FTVDBF) infant has been considered as the standard for a 64 
healthy infant microbiota and recent studies have tried to define its composition15,16. 65 
Indeed, the promotion of a microbiota resembling that of the FTVDBF infant has been 66 
considered as a target for improving infant formulas17. Preterm infants present an 67 
immature immune system18 and a compromised gut mucosa19. These represent a 68 
risk for both vertically transmitted infections and late-onset nosocomial infections. In 69 
these newborns the process of microbiota establishment is also affected, presenting 70 
an increased abundance of Enterobacteriaceae, a delayed colonization by 71 
commensal bacteria and a higher colonization by pathogens such as Klebsiella sp., 72 
than full-term babies7,8,9,20.  73 
The aim of the present study was to assess the process of establishment of the 74 
intestinal microbiota in very-low birth-weight (VLBW) preterm infants, compared with 75 
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that of FTVDBF neonates, and to evaluate the impact of perinatal factors, such as 76 
the delivery mode and antibiotics use, in this process. To this end we applied an Ion 77 
Torrent 16S rRNA gene sequence-based microbiota analysis and quantitative PCR 78 
(qPCR) of specific microbial groups.  79 
Methods 80 
Volunteers. The study was approved by the Regional Ethical Committee of Asturias 81 
Public Health Service (SESPA) and informed written consent was obtained from the 82 
parents. Thirteen caucasian FTVDBF infants, (7 males/6 females) born after an 83 
uncomplicated pregnancy, and twenty-seven caucasian very low birth weight (VLBW) 84 
preterm infants (12 males/15 females) were recruited at the Neonatology Units of 85 
Cabueñes Hospital and Central University Hospital (HUCA) from Asturias (Spain). All 86 
full-term infants were vaginally delivered, at a gestational age between 37 and 41 87 
weeks (mean 39.2) with birth weights between 3020 and 4160 grams, were 88 
exclusively breast-fed and were discharged from the hospital at the third day of life. 89 
Preterm infants (7 delivered vaginally and 20 by caesarean section) were born at a 90 
gestational age between 24 and 32 weeks (mean 29.6) and their birth weights 91 
ranged between 690 and 1,800 grams. None of the infants suffered NEC or 92 
presented culture positive early onset infection. With regard to antibiotic 93 
administration none of the full-term infants received antibiotics but three mothers 94 
received intrapartum antimicrobial prophylaxis (IAP) (in all cases a single dose of 95 
ampicillin). Fourteen of the preterm infants’ mothers received IAP. One of these 96 
mothers received a single dose of penicillin and other mother was administered 97 
ampicillin for three days (one dose every six hours). The rest of the mothers received 98 
ampicillin plus erythromicin (between two and 24 doses of each antibiotic). Twelve 99 
infants received antibiotics at birth (all of them ampicillin plus gentamicin during 5-8 100 
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days) whilst five extra infants started to receive antibiotics later on, three of them 101 
starting before 10 days of life and two infants starting at 12-13 days of life (three 102 
cases vancomycin plus amikacin, one vancomycin and one gentamycin plus 103 
clindamycin plus teichomycin). Only 5 out of the 27 mother/premature infant pairs did 104 
not receive antibiotics, either intra-partum or postnatally, during the sampling period 105 
whilst in 9 of the pairs both, mother and infant, received antibiotics. All preterm 106 
infants received mixed feeding (infant formula and some sporadic breast-milk 107 
administration along the study) and were discharged from the hospital after an 108 
average hospital stay of 50 (range 21-93) days. 109 
Sample Collection. Fecal samples were collected at the hospital at two (between 24 110 
and 48 hours of life), 10, 30 and 90 days of age. The first spontaneous or stimulated 111 
(after perianal stimulation) deposition was taken in a sterile container, immediately 112 
frozen at -20ºC and sent, within a week, to the laboratory. 113 
Microbiota analyses by Ion Torrent PGM sequencing of 16S rRNA gene-based 114 
amplicons. DNA was extracted from fecal samples as previously described20 and 115 
kept frozen at -80ºC until analysis. DNA was PCR-amplified, sequenced in a 316 chip 116 
at GenProbio Ltd (www.genprobio.com) by using the Ion Torrent PGM system and 117 
the Ion Sequencing 200 kit (Life Technologies) and analysed as recently reported21 118 
using the QIIME software suite. Quality filtering allowed to retain only full length 119 
reads with quality >25 that were used to construct de novo OTUs using uclust 120 
software and 97% sequence identity as threshold. Reference sequences for each 121 
OTUs were identified and used for OTUs taxonomic assignment based on a 122 
reference dataset from the Ribosomal Database Project. Hierarchical clustering was 123 
constructed using the MeV software and the Pearson’s correlation as distance 124 
metric. 125 
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Quantitative PCR Analysis. For quantification of total fecal bacteria the qPCR 126 
conditions and primers described elsewhere22 were used. Quantification of the 127 
different bacterial populations assessed was achieved as previously reported20. 128 
Statistical analyses. Results were analyzed using the SPSS software (SPSS Inc. 129 
Chicago, USA). The normality of the data, at each sampling point, was checked 130 
using the KS test. For normal variables, one-way anova followed by post-hoc 131 
bonferroni’s test was used. Some of the bacterial groups showed non-normal 132 
distribution, then the differences between groups of infants were analyzed using the 133 
non-parametric Kruskal-Wallis test or, in the case of pairwise comparisons, the 134 
Mann-Whitney U-test.  135 
Nucleotide sequence accession numbers. The raw sequences from the samples 136 
reported in this article have been deposited in the NCBI Short Read Archive (SRA) 137 
under the BioProject ID code PRJNA230470. 138 
Results 139 
Establishment of intestinal microbiota in VLBW preterm neonates as compared 140 
with FTVDBF infants. Ion Torrent sequencing of the PCR products obtained by 141 
amplification of the V3-V4 region of the 16S rRNA gene from the 160 fecal samples 142 
analysed in this study yielded, after filtering, about ~ 105 sequences per sample with 143 
an average length of 196 bp. We found noticeable differences in the development of 144 
the intestinal microbiota composition between preterm and FTVDBF babies (Figure 145 
1). Two days-old preterm newborns showed significantly (p<0.05) lower proportions 146 
of the families Bacteroidaceae, Clostridiaceae, Micrococcaceae, Pasteurellaceae and 147 
Porphyromonadaceae and higher (p<0.05) of Bifidobacteriaceae, Comamonadaceae, 148 
Propionibacteriaceae, Streptococcaceae, unclassified Actinobacteria, unclassified 149 
Bacilli or unclassified Lactobacillales and specially of Lactobacillaceae than FTVDBF 150 
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infants. At 10 days of age preterm infants displayed a significant reduction (p<0.05) in 151 
the percentage of Bacteroidaceae, Bifidobacteriaceae, Clostridiaceae, 152 
Coriobacteriaceae, Leuconostocaceae, Pasteurellaceae, Porphyromonadaceae, 153 
unclassified Actinobacteria  and Veillonellaceae, and a higher percentage (p<0.05)  154 
of the families Enterobacteriaceae, Micrococcaceae and unclassified 155 
Gammaproteobacteria than FTVDBF babies. This situation remained relatively stable 156 
during the rest of the study, with significantly (p<0.05) higher proportions of 157 
Enterobacteriaceae and significantly (p<0.05) lower of Bacteroidaceae in preterm 158 
infants at 30 and 90 days of age as the main observation during this period. 159 
The qPCR results showed that the levels of most microbial groups tended to 160 
increase over time, with notable differences in bacterial levels observed between 161 
both groups of infants (Figure 2, online). Feces from preterm newborns showed 162 
significantly lower levels (p<0.05) of total bacteria at two days of life, but higher at 10 163 
days than FTVDBF infants, with an almost identical trend observed for the 164 
Enterobacteriaceae family. In feces from preterm infants Enterococcaceae levels 165 
were lower (p<0.05) at two days of age, but significantly higher after 30 days, than in 166 
those of FTVDBF infants.  Moreover, premature infants showed lower levels of most 167 
of the other microbial groups analyzed. These results indicate that the surprisingly 168 
high percentage of lactobacilli sequences found in the 16S rRNA profiling analysis in 169 
two days-old preterm infants are due to reduced levels of total bacteria, rather than to 170 
higher absolute level of lactobacilli in feces from this infant group. 171 
Impact of delivery mode and antibiotics use on the establishment of 172 
intestinal microbiota. The mode of delivery was found to have limited effect on the 173 
gut microbiota composition of the preterm newborns. No differences were observed 174 
on the 16S rRNA profiling data between vaginally delivered preterm infants and those 175 
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born by caesarean section, whilst the only difference observed by qPCR regarded 176 
higher levels of Bacteroides in vaginally delivered babies at 10 days of age (5.31 ± 177 
1.39 vs. 4.24 ± 0.48 log cells/g, p<0.05). 178 
In contrast, antibiotics use was found to have a profound impact on the 179 
intestinal microbiota establishment process. When cluster analysis was performed by 180 
including preterm infants classified into four groups, depending on mother and infant 181 
antibiotic use, as well as full-term infants not exposed to antibiotics as external group, 182 
an effect of perinatal antibiotics became evident (Figure 3). IAP was found to have an 183 
equal or even higher effect than direct administration of antibiotics to the infant during 184 
the first days of life. Interestingly, this effect was not so apparent in the first sampling 185 
points, when the only statistically significant differences (p<0.05) were the higher 186 
percentage of sequences from Leuconostaceae at two days of age and the higher 187 
percentage of sequences from Micrococcaceae and Propionibacteriaceae at 10 days 188 
in the infants not exposed to antibiotics, neither directly nor through IAP, than in the 189 
other three groups. However, at 30 days of age several statistically significant 190 
differences were observed, with the infants not exposed to antibiotics (either directly 191 
or via their mothers) showing higher relative abundances of Comamonadaceae, 192 
Staphylococcaceae and unclassified Bacilli than the other three groups (p<0.05). At 193 
this time points infants not exposed to antibiotics also presented significantly higher 194 
percentage (p<0.05) of Bifidobacteriaceae, Streptococcaceae, unclassified 195 
Actinobacteria and unclassified Lactobacillales and lower (p<0.05) of 196 
Enterobacteriaceae than both groups of infants whose mothers received IAP 197 
(independently on whether or not the infant itself received antibiotics). However, 198 
these no-antibiotics exposed infants group did not differ (p>0.05) from the group of 199 
infants that received antibiotics but whose mothers did not receive them. After 90 200 
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days of age, most of these differences have disappeared being Ruminococcaceae 201 
the only family showing statistically significant differences among groups.  202 
It is important to underline that the four groups of infants defined by antibiotics 203 
use did not differed statistically at any time point regarding birth-weight or length of 204 
hospital stay. At two and 10 days of life the group in which both mothers and infants 205 
received antibiotics showed a significantly lower (p<0.05) gestational age than those 206 
in the group in which neither the mother nor the infant received antibiotics, but no 207 
differences were found with the other infant groups. This difference disappeared at 208 
later sampling points (30 and 90d) due to new infants receiving antibiotics and, 209 
therefore, changing to the antibiotics group. 210 
Interestingly, although the number of full-term infants whose mothers received 211 
IAP is very limited (n=3) the comparison of these babies with the non-antibiotics 212 
exposed full-term babies (n=10) also suggests a profound effect of IAP in full-term 213 
newborns (Figure 4; online), even when these three mothers having IAP received 214 
only a single dose of ampicilin. 215 
In accordance to that stated above, qPCR analyses did not show any 216 
statistically significant differences among groups at 2 or 10 days of age. However, at 217 
30 days statistically significant differences (p<0.05) were observed for 218 
Staphylococcaceae, Enterobacteriaceae and total bacteria, the levels of the first 219 
microorganism being higher in preterm infants not exposed to antibiotics than in the 220 
other three infant groups, whilst the contrary was true for Enterobacteriaceae and 221 
total bacteria. At 90 days of age the only difference observed referred to the higher 222 
levels (p<0.05) of bifidobacteria in the non-antibiotics exposed infants (data not 223 
shown). 224 
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Discussion 225 
Despite the high inter-individual variability, the 16S rRNA profiling analysis 226 
evidenced an altered pattern of intestinal microbiota establishment in extreme 227 
preterm infants when compared with FTVDBF babies. It is important to underline, 228 
however, that very often prematurity is present together with different potential 229 
confounding factors which difficult the interpretation of the data. To this regard, our 230 
preterm cohort received mixed feeding, with none of the infants being exclusively 231 
breast-fed, whilst our control group included exclusively breast-fed babies. Therefore, 232 
the potential impact of the different feeding habits cannot be overruled as a factor 233 
contributing to explain the differences observed between both groups of infants. In 234 
our study the most striking observation was, perhaps, the reduced percentage of 235 
sequences belonging to the family Bacteroidaceae found in preterm (1% of 236 
sequences) with regard to that in FTVDBF babies (~ 20%) during the whole duration 237 
of the study. This observation was confirmed by qPCR and it is in agreement with 238 
that previously reported for non-VLBW premature babies20. Other noticeable 239 
differences regarded the reduced levels of total bacteria and higher relative 240 
proportion of Lactobacillaceae during the first hours of life, followed by a dominance 241 
of Enterobacteriaceae, starting during the first days and remaining up to the three 242 
months of age, in our VLBW preterm infants. These observations are in agreement 243 
with previous reports indicating an increased occurrence of potential pathogenic 244 
enterobacteria, as well as a high inter-individual variability in preterm babies9,20,23.  245 
Delivery mode and antibiotics treatment are two factors that may affect 246 
microbiota composition. In our preterm infants group the delivery mode had a limited 247 
effect on gut microbiota composition, in contrast to what has been previously 248 
reported for full-term infants24. The only difference observed suggested a delayed 249 
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colonization by Bacteroides during the first days of life in cesarean section (CS) 250 
delivered newborns, which has been previously reported in full-term infants25. The 251 
use of antibiotics may disrupt the neonatal gut microbiota having profound 252 
consequences for later health26. Indeed, recent animal studies demonstrate that 253 
antibiotic-mediated disturbance of the intestinal microbiota in the very early life can 254 
increase the risk of late-onset sepsis27. Here we have assessed the effect of 255 
antibiotics administration, either as IAP to the mother or directly to the infant, upon 256 
gut microbiota establishment. Our results indicate an effect of IAP administration. 257 
This effect was not immediate as it was hardly detected the first days after delivery 258 
but becomes apparent later on. At one month of age infants whose mothers received 259 
IAP showed an intestinal microbiota different from that of those infants whose 260 
mothers did not receive it. Noteworthy, at this sampling time no statistically significant 261 
differences were observed among the four preterm infant groups in background 262 
variables such as gestational age, birth-weight or length of hospital stay. 263 
Similarly, effects of IAP administration seem to be also present in full-term 264 
infants. Although previous studies did not observe any effect of maternal antibiotics 265 
consumption during pregnancy upon infant gut microbiota28, others evidenced an 266 
effect of maternal perinatal antibiotics use on the fecal microbiota of full-term 267 
infants29. Also with full-term infants, other studies have reported that antibiotics 268 
administration during the first hours of life caused a reduced level of intestinal 269 
Bifidobacterium in the immediate days after administration and increased levels of 270 
Enterobacteriaceae later on30,31. These suggesting a lasting effect of early-life 271 
antibiotic administration upon gut microbiota composition, which is in good 272 
agreement with our observations. Similarly, incomplete recovery of the gut microbiota 273 
after antibiotics administration has been demonstrated in adults32.  274 
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Our results indicate that immaturity affects intestinal microbiota composition and 275 
it accounts for some of the differences observed between preterm and FTVDBF 276 
infants, such as the reduced percentage of Bacteroidaceae during the first months of 277 
life or the higher percentage of Lactobacillaceae during the first days of life. However, 278 
in some other of the differences observed, such as the increased Enterobacteriaceae 279 
levels in preterm infants, the antibiotics exposure seems to have a role. To this 280 
regard, IAP seems to exert a critical influence in the early intestinal microbiota. 281 
Therefore, it may be time for considering the potential deleterious effects upon gut 282 
microbiota composition when deciding on antibiotic use. According to the data from 283 
the Spanish Society for Neonatology (www.se-neonatal.es) in Spain about half of the 284 
mothers of VLBW infants receive IAP. Overall, in developed countries IAP is used in 285 
over 30% of total deliveries33. In spite of not being a clearcut decision pre-partum 286 
antibiotics are generally recommended in the case of premature rupture of 287 
membranes or when vaginal colonization by group B streptococci is detected, 288 
however, they are also frequently used in other clinical situations in which a clear 289 
benefit has not been demonstrated34. This, together with the high number of infants 290 
receiving antibiotics for what later on results to be a noninfectious cause has raised 291 
some concerns35. In addition, recent data suggest that perinatal antibiotics-mediated 292 
microbiota disturbance increases the risk for late-onset sepsis and NEC which may 293 
constitute a life threatening risk for preterm newborns36. Moreover, very often broad-294 
spectrum antibiotics are used which seems to drastically affect the early gut 295 
microbiota establishment process.  296 
Given the importance of the microbial gut colonization during the neonatal 297 
period it is important to minimize the impact on the early microbiota of any medical 298 
intervention. This study identifies alterations on the process of establishment of the 299 
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intestinal microbiota in preterm infants and points out effects of antibiotics upon this 300 
process. These results may be the basis for designing intervention strategies 301 
targeting to favor the gut microbiota establishment, and to minimize the impact of 302 
medical interventions in early life on this process 303 
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Figure legends 420 
Figure 1. Aggregate microbiota composition at family level in fecal samples from 421 
term and preterm infants at the different time points analyzed. 422 
Figure 2. Online only. Fecal levels (mean ± SD) of the different microorganisms 423 
analyzed by qPCR in samples from term and preterm infants at the different time 424 
points analyzed (2, 10, 30 and 90 days). Asterisks indicate statistically significant 425 
differences (p < 0.05). 426 
Figure 3. Hierarchical clustering based on composition, at family level, of samples 427 
collected at the different times from term infants not exposed to antibiotics and the 428 
four groups of preterm infants classified as a function of the maternal and/or infant 429 
antibiotic administration. Every samples’ group is associated with its own aggregate 430 
representation at family level.  431 
Figure 4. Online only. Aggregate microbiota at family level, of samples collected at 432 
the different time points from term infants whose mother received a single dose of 433 
IAP with ampicilin (n=3) and those whose mothers did not receive IAP (n=10). 434 
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